InsidersTradesSigma
Follow the 复旦张江 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 复旦张江 has recorded 17 reports. Market capitalisation: €7.5bn. The latest transaction was filed on 10 December 2024 (Sale). Among the most active insiders: 苏勇. Every trade is free.
17
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
17 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,095 of 29,063 companies
39.0
score / 100
Value37
Quality41
FCF yld1.5%
Earn yld-2.1%
EV/EBITDA·
ROE-6.9%
Gross mgn90%
Net mgn-23%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 December 2024
Declarations17 total
17 of 17 declarations
关于 复旦张江
Fudan Zhangjiang 是一家医疗保健和制药领域的公司，在上海证券交易所上市。它专注于创新药物的研发。